Effect of Panax Ginseng C.A. Mey Extract on Liver Function in Adults

Launched by PUSAN NATIONAL UNIVERSITY YANGSAN HOSPITAL · Dec 11, 2018

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a natural supplement called Panax Ginseng C.A. Mey Extract on liver function in adults who have certain liver conditions. The research will last for 8 weeks and will involve people who have mild liver issues, specifically looking at those whose liver enzyme levels are elevated but not excessively high.

To participate, individuals must be adults between the ages of 18 and 75 who meet specific health criteria, such as having liver enzyme levels that are slightly elevated but within a certain range. However, those with more serious liver or kidney problems, diabetes, a history of certain diseases, or who have taken specific medications recently are not eligible to join. Participants will receive either the ginseng extract or a placebo (a non-active treatment) without knowing which one they are getting. This trial is currently looking for volunteers, and those who join can contribute to understanding how this herbal supplement might help improve liver health.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • ALT ranging from upper limit of reference to three times of upper limit
• Exclusion Criteria:
• • Abnormal liver or renal function (i.e., serum aminotransferase activity \> 3 times of upper limit of reference range and serum creatinine concentrations \> 1.2 mg/dL)
• • Diabetes (diagnosed clinically or fasting glucose level \> 126 mg/dL)
• • History of viral hepatitis or cancer
• • Uncontrolled hypertension
• • History of serious cardiac disease such as angina or myocardial infarction
• • History of gastrectomy
• • History of medication for psychiatric disease
• • Administration of oriental medicine including herbs within the past 4 weeks